Oxford Cancer Biomarkers

South East England

Molecular and digital biomarkers for personalised cancer treatment

Oxford Cancer Biomarkers is a precision oncology diagnostics company developing molecular and digital pathology tests to support personalised cancer treatment.

Its pharmacogenomic assays assess inherited variants associated with fluoropyrimidine chemotherapy toxicity, while its algorithm-driven pathology tools analyse tumour characteristics to stratify colorectal cancer recurrence risk. The company combines biomarker research, genetic analysis and clinical validation to inform treatment selection and support oncologists in interpreting individual patient risk.

Biotech Oncology Diagnostics & Biomarkers AI & Machine Learning

Clinical Diagnostics Genotyping

Is this your company?

Claim this page to receive a verified badge and keep your profile up to date.

Claim page

Company Notes

AKA / Aliases

OCB

Similar Companies